ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
ALK Abello AS

ALK Abello AS (4AJ0)

19.78
0.15
( 0.76% )
Updated: 04:57:41
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
19.78
Bid
19.84
Ask
19.85
Volume
43
19.55 Day's Range 19.78
19.05 52 Week Range 24.56
Previous Close
19.63
Open
19.55
Last Trade
42
@
19.78
Last Trade Time
03:48:13
Average Volume (3m)
257
Financial Volume
-
VWAP
-

4AJ0 Latest News

ALK – Financial calendar for the 2025 financial year

ALK – Financial calendar for the 2025 financial year 2025 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF): 22 January 2025:                      Silent period                        19...

Positive results advance peanut tablet to phase II development

Positive results advance peanut tablet to phase II development ALK’s peanut tablet shown to be safe and tolerable across multiple doses.Development now advances to phase II for dose finding and...

ACARIZAX® approved in Europe for treatment of young children

ACARIZAX® approved in Europe for treatment of young children ALK (ALKB:DC / OMX: ALK B) today announced that its European regulatory filing for ACARIZAX® (house dust mite sublingual allergy...

ALK’s pivotal phase 3 trial in children published in reputable scientific journal

ALK’s pivotal phase 3 trial in children published in reputable scientific journal The reputable scientific journal, The Lancet Regional Health – Europe, has published robust results from ALK’s...

Nine-month interim report (Q3) 2024 (unaudited)

Nine-month interim report (Q3) 2024 (unaudited) Company release No. 19/2024 ALK delivers 18% organic revenue growth and an operating profit margin of 23% in Q3 Revenue growth was mainly driven by...

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis) ALK (ALKB:DC / OMX: ALK B) today announced that it has entered...

Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024

Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024 ALK (ALKB:DC / OMX: ALK B / AKBLF) will publish its results for the first nine...

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014...

Six-month interim report (Q2) 2024

Six-month interim report (Q2) 2024 Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a...

ALK upgrades its full-year revenue and earnings outlook

ALK upgrades its full-year revenue and earnings outlook ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the full-year financial outlook has been upgraded to reflect the current performance...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.58-2.8487229862520.3620.55999919.514319.89776739DE
4-0.82-3.9805825242720.621.819.5112320.97207342DE
12-2.18-9.9271402550121.9622.6419.5125721.43427439DE
26-0.92-4.4444444444420.724.5619.1331722.24945338DE
52-0.9-4.3520309477820.6824.5619.0531921.8712846DE
156-0.9-4.3520309477820.6824.5619.0531921.8712846DE
260-0.9-4.3520309477820.6824.5619.0531921.8712846DE

4AJ0 - Frequently Asked Questions (FAQ)

What is the current ALK Abello AS share price?
The current share price of ALK Abello AS is 19.78 €
What is the 1 year trading range for ALK Abello AS share price?
ALK Abello AS has traded in the range of 19.05 € to 24.56 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
E3O1Nexoptic Technology Corp
0.023 €
(48.39%)
43.48k
PU11Social Chain AG
0.024 €
(23.71%)
57.05k
LN00Cult Food Science Corp
0.0396 €
(22.22%)
1.09k
RD31Royal Helium Ltd
0.0186 €
(20.78%)
11k
JT71Australian Vanadium Limited
0.0099 €
(20.73%)
266.43k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
2.17k
7KOCullinan Metals Corp
0.0072 €
(-35.71%)
216.5k
LL3PanGenomic Health Inc
0.0901 €
(-29.39%)
4
L09Lithium Energi Exploration Inc
0.0155 €
(-26.19%)
2k
0I5ABettermood Food Corporation
0.232 €
(-22.92%)
18k
PF8European Lithium Limited
0.0384 €
(10.34%)
3.74M
D7GNel ASA
0.19 €
(-1.30%)
2.34M
RQ0DWave Quantum Inc
5.452 €
(18.37%)
1.92M
3MWLivium Ltd
0.0102 €
(4.08%)
433.35k
BVBBorussia Dortmund KGAA
2.935 €
(-3.45%)
412.57k

Discussion

View Full Feed
TrendTrade2016 TrendTrade2016 9 minutes ago
SUPER STAR CEO RAN AWAY WITH THE LOOT..OLE SCHOOL RINSE THE DEBT...THOSE TORONTO BOYS WORKED YA GOOD HERE..SCAM IS DONE!
TWOH
Atlanta1 Atlanta1 14 minutes ago
so it looks like we're screwed
CRTG
P-Rawl P-Rawl 16 minutes ago
Have smallcapvoice given up on him or can he no longer afford their $5,500 a month fee? They haven't posted anything for weeks, apart from a notice about a forthcoming video back on December 17th which was meant to answer shareholder questions. Still no sign of that video.
SONG
Drugdoctor Drugdoctor 21 minutes ago
$GBIO .88 - Nasdaq Bios are hot! INSIDER-BUY-Quinn Anthony G. (Director) Buys 210,791 @ Avg Price: $0.96 - Balance Sheet
Total Cash (mrq)184.77M-Total Cash Per Share (mrq)2.77
GBIO
TrendTrade2016 TrendTrade2016 22 minutes ago
LMAO STOP PRETENDING
FNMA
lakers17 lakers17 23 minutes ago
Took a starter in SOLO at .0043

Contract 0xD61A8BbD5C6d8Cd9690a89616b33dC939C9FbDA9

https://x.com/SoloDePIN
TrendTrade2016 TrendTrade2016 24 minutes ago
THAT WAS A BULL RUN ALRIGHT...IT WAS WASHED UP TO ALLOW OWNERS TO RINSE THE RAG...LOST MAN!
RDAR
Cornerstone_Marketing Cornerstone_Marketing 27 minutes ago
I would be interested in knowing who you work for. NO REAL PERSON spends all day bashing and misdirecting people. 
Every post of yours is garbage - many are just scare tactics or posting articles on companies not related to Spzi to infer "something bad" is coming.

If in fact yo
SPZI
Iggy_Bot Iggy_Bot 28 minutes ago
Sooooooonnnnnnnnnnnnnnn
Guzzi62 Guzzi62 28 minutes ago
They don't, not possible.

It's the regulators that are slow, maybe understaffed, the UK economy is not in a good shape.
NWBO
Sooth_Sayer Sooth_Sayer 29 minutes ago
More dilution?
GORO
lakers17 lakers17 37 minutes ago
Locked and loaded in PAI now:

Q1 2025 is going to be a game changer for $PAI!

We’re rolling out ParaHub and ParaGen, pushing the boundaries of parallel computing with Parilix, and leveling up AI optimization with PACT. It's all about making AI deployment faster, smarter
PAI
FortunaFavetFortibus FortunaFavetFortibus 40 minutes ago
pre-conservatorship they were issuing dividends at $1-2/share per year on annually profits of $3-5B
with current profits 5X-4X that level, a $10/share div annually is on the high end but still within the math of that dividend model
and F&F are not entities that require much re-investme
FNMA
knrorrel knrorrel 43 minutes ago
I bought a third time yesterday and I think the stock will make a big upward move in the long term.

ALSCF
knrorrel knrorrel 44 minutes ago
great $ALSCF tweet https://x.com/AlsetAI/status/1876737840207347980?t=rj9nA2loOQyUKcASp_UzAA&s=19
ALSCF
QueenVic QueenVic 48 minutes ago
Warren might slip up and say "bail out". And then try to cover her tracks.

Too many unjustifiable words she has to question - 💤💤💤
A friggin waste of time she is
capgain capgain 51 minutes ago
Good morning, RR. “It’s critically important that, to the extent you can find anything that gives you an ability to be patient in this extremely dangerous and unprecedented crisis, that you do,” LOL, Just kidding :)

Straight up, I like all the home teams in the NFL this weekend. KC, D
Calvin Hobbes Calvin Hobbes 52 minutes ago
It's possible. They do need to update the GGSM one though as well and get all the info that is in filings in there as well. There is a lot of info they could add.
GGSM
QueenVic QueenVic 53 minutes ago
😂😁🫢

Elizabeth "Chief Princess of Running mouth" Warren was sooooo irrelevant at questioning the nominee Pete Hegseth (Secretary Dept of defense) and she and the cronies around her basically are people who word fight and bully their way- to no avail.
QueenVic QueenVic 1 hour ago
I felt the same way. It's too bad that people are suffering from this

The DEI is a farce, and places hired individuals that are not qualified for the jobs it's beyond mental and physical capabilities you need to be in tip top shape no matter what and on call 24/7.

The
threewheeler threewheeler 1 hour ago
01/15/2025 Expert Market IconCRTG The Coretec Group Inc. OTCQB Expert Market Common Stock
CRTG
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 hour ago
People who bought the december offering at $3 a share sure are tasting some pain. Surprise the underwriters arent supporting the stock better.
IBRX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 hour ago
ImmunityBio has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of its common stock at the public offering price
I wonder if the underwriters exercised this option or not. $3 share price doesnt look to great a deal at the moment.
IBRX
martyDg martyDg 1 hour ago
Does the big red in your nwbo position tell you it's derisked? LOL 
NWBO
GrantHorvat1 GrantHorvat1 1 hour ago
It sure is...

If anyone wants to know what a totally clean, debt free shell looks like check out GVSI's latest annual...2024's will be filed imminently as well...the 8th of 2 years of Q's...we all know what that means and when it does it will set in motion a chain of events that will
GVSI

Your Recent History

Delayed Upgrade Clock